Early Life and Education
Robert W. Duggan was born in Oakland, California, in 1944. He attended St. Francis High School, where he was the quarterback. He studied business and economics at the University of California, Santa Barbara, and UCLA, although he did not complete a degree. His early experiences included working as a baker and enjoying surfing.
Career Highlights and Rise to Success
Duggan's entrepreneurial journey began with his first company, Sunset Designs. He later transitioned to the tech sector, serving as CEO of Computer Motion from 1997 to 2003, a company that developed robotic surgical systems. However, his most significant financial success came from his involvement with Pharmacyclics. He invested in Pharmacyclics in 2004 and became its CEO in 2008. Under his leadership, Pharmacyclics developed Imbruvica, a breakthrough cancer drug that became a major revenue driver, particularly for treating leukemia and lymphoma. Duggan orchestrated the sale of Pharmacyclics to AbbVie in 2015 for $21 billion, which solidified his position as one of the wealthiest figures in biotechnology.
Key Business Strategies
Duggan's success is attributed to his strategic investments in biotechnology and his leadership in developing life-saving medical treatments. Duggan focuses on identifying and investing in transformative medical innovations, turning struggling companies into thriving ventures through his strategic leadership and vision.
Philanthropy
Duggan is also known for his extensive philanthropic activities. He has served on the board of trustees at UCSB since 1989. He has donated significantly to educational endeavors such as athletic departments, the UC Santa Barbara Gold Circle Society, and faculty chair positions in Mathematics and in Life and Physical Sciences. Duggan is also a founding donor of the Institute for Energy Efficiency at UCSB.